Title: Driving Neuroplastic Change in Stroke Survivors: Leading-Edge Treatments, Tools and Strategies.
DAY ONE
Designed to take the complexity and guesswork out of planning treatment, this seminar affirms a new perspective on stroke recovery. Based on principles proven to drive neuroplastic change in stroke survivors, this seminar will provide the tools necessary to seamlessly incorporate leading-edge, research-based recovery options singularly, and in tandem. Included will be an in-depth discussion of a variety of strategies, technologies and treatment options emerging from research labs around the world that are designed to aid stroke survivors in reaching the highest level of potential recovery.

DAY TWO
On Day two, participants will learn modified constraint induced therapy (mCIT), a new reimbursable treatment approach that has received a lot of media coverage for its success. Other strategies that will also be discussed, include gaming technologies, motor imagery techniques, EMG-based electrical stimulation (ie. NeuroMove) and functional electrical stimulation (ie. Bioness), and more. Evidence based measures of progress are also taught on Day Two. Jointly Peter Levine and Stephen Page developed Modified Constraint-Induced Therapy. They have published the studies on the technique. Now, come learn this cutting edge technique from the originators!